1. Godeau B. Immune thrombocytopenic purpura: major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues. Presse Med. 2014;43(4 Pt 2):e47‐e48. [PubMed] [Google Scholar] 2. Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):945‐955. [PubMed] [Google Scholar] 3. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190‐4192. [PubMed] [Google Scholar] 4. Lee MS, Kim WC. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: report of seven patients and a meta‐analysis. Neurology. 1998;50(4):1160‐1163. [PubMed] [Google Scholar] 5. Despotovic JM, Grimes AB. Pediatric ITP: is it different from adult ITP?. Hematology Am Soc Hematol Educ Program. 2018;2018(1):405‐411. [PMC free article] [PubMed] [Google Scholar] 6. Stasi R, Stipa E, Masi M, et al. Long‐term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436‐442. [PubMed] [Google Scholar] 7. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168‐186. [PubMed] [Google Scholar] 8. Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Acta Paediatr Taiwan. 2006;47(5):226‐231. [PubMed] [Google Scholar] 9. George JN, Kojouri K, Perdue JJ, Vesely SK. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000;37:290‐298. [PubMed] [Google Scholar] 10. Giagounidis AA, Anhuf J, Schneider P, et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti‐CD20 monoclonal antibody rituximab: a pilot study. Eur J Haematol. 2002;69(2):95‐100. [PubMed] [Google Scholar] 11. Siegal D, Crowther M, Cuker A. Thrombopoietin receptor agonists in primary ITP. Semin Hematol. 2013;50(01):S18‐S21. [PMC free article] [PubMed] [Google Scholar] 12. Hauswirth AW, Skrabs C, Schützinger C, et al. Autoimmune thrombocytopenia in non‐Hodgkin's lymphomas. Haematologica. 2008;93(3):447‐450. [PubMed] [Google Scholar] 13. Fallah M, Liu X, Ji J, Försti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non‐Hodgkin lymphoma: a nationwide cohort study. Ann Oncol. 2014;25(10):2025‐2030. [PubMed] [Google Scholar] 14. Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol. 1992;48:168‐172. [PubMed] [Google Scholar] 15. Chiao EY, Engels EA, Kramer JR, et al. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med. 2009;169(4):357. [PMC free article] [PubMed] [Google Scholar] 16. Bougie DW, Wilker PR, Aster RH. Patients with quinine‐induced immune thrombocytopenia have both "drug‐dependent" and "drug‐specific" antibodies. Blood. 2006;108(3):922. [PMC free article] [PubMed] [Google Scholar] 17. Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopenia. J Thromb Haemost. 2013;11(1):169‐176. [PMC free article] [PubMed] [Google Scholar] 18. Karpp D. The favored ingredient of a seasonal Latino punch cannot be imported, so San Diego County farmers came up with a solution. LA Times 12/9/2009. 19. Núñez‐Colín CA, Sanchez D. Ethnobotanical, cultural, and agricultural uses of tejocote (Crataegus species) in Mexico. Acta Horticulturae. 2011;918:901‐910. [Google Scholar] 20. Crataeguspubescens (Kunth) Steud. (1841). NomenclatorBotanicus. 2: 433. 1841. 21. Bray JK, Chiu GS, McNeil LK, et al. Switching from a high‐fat cellulose diet to a high‐fat pectin diet reverses certain obesity‐related morbidities. Nutr Metab (Lond). 2018;15:55. [PMC free article] [PubMed] [Google Scholar] 22. Alipotec Tejocote Root Review ‐ 9 Things You Need to KnowBy Summer Banks FNS, SPT, Natalie Rizzo, MS, RD (expert review). https://www.dietspotlight.com/alipotec-tejocote-root-review/ 23. Palmer K, Lebin J, Burns R, Mazor S. Tejocote Raíz: a root for weight‐loss or digoxin doppelgänger? ACMT 2019 annual scientific meeting abstracts—San Francisco, CA. J Med Toxicol. 2019;15(2):53‐107. [Google Scholar] 24. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386‐2393. [PubMed] [Google Scholar] 25. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug‐induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7(6):911‐918. [PMC free article] [PubMed] [Google Scholar] 26. Núñez‐Colín CA. The tejocote (Crataegus Species): a Mexican plant genetic resource that is wasted. Acta Horticulturae. 2009/01/01. 10.17660/ActaHortic.2009.806.42. Page 2Tejocote Tree. Source Ref. 26 Click on the image to see a larger version. |